Skip to content
Clinical Trials – home
Therapeutic area

Nervous system disorders – page 61

  • 1 389 clinical trials
  • 585 recruiting
  • 453 conditions
  • 29 countries

Conditions in this area

453 conditions with trials, the busiest first

Clinical trials in Nervous system disorders

1 389 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

1 389 clinical trials

Glioblastoma

Not yet recruiting

Study on Using Iron Oxide to Visualize Tumor Spread in Glioblastoma Patients

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Sponsor:Stichting Radboud University Medical Center

Dementia Alzheimer's type

Not yet recruiting

Study on Brain Changes in Alzheimer's Disease Using Flortaucipir (18F) for Patients with Alzheimer's and Its Variants

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Flortaucipir (18F)
  • Sponsor:Inserm

Pneumonia bacterial+1

Not yet recruiting

Study on Preventing Early Respiratory Infections in Intubated Patients Using Ceftriaxone, a Cough Simulator, and Subglottic Secretion Aspiration

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Ceftriaxone
  • Sponsor:Hospital Clinico San Carlos

Diabetic foot

Not yet recruiting

Study on AUP1602-C for Treating Non-Healing Diabetic Foot Ulcers in Patients

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Aup1602-C
  • Sponsor:Aurealis Oy

Autism spectrum disorder+1

Not yet recruiting

Study on the Effects and Safety of Fecal Microbiota Transplant in Children with Autism and Digestive Issues

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Allogeneic Faecal Microbiota, Pooled
  • Sponsor:Assistance Publique Hopitaux De Paris

Neuroblastoma

Not yet recruiting

Study of Anti-GD2-800CW for Imaging in Children with Neuroblastoma

InvestigationalNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years
  • Substances:ANTI-GD2-800CW
  • Sponsor:Princess Maxima Center For Pediatric Oncology

Study on the Safety and Effects of YTB323 and Drug Combination in Patients with Progressive Multiple Sclerosis

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Cyclophosphamide
  • Sponsor:Novartis Pharma AG

Study on the Safety and Effects of YTB323, Tocilizumab, and Cyclophosphamide in Patients with Relapsing Multiple Sclerosis Who Have Active Disease Despite Treatment

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Cyclophosphamide
  • Sponsor:Novartis Pharma AG

Ischaemic stroke

Not yet recruiting

Study on the Effects of CD34+ Cells for Patients with Acute Ischemic Stroke

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:AUTOLOGOUS CD34+ ENRICHED CELL FRACTION THAT CONTAINS CD34+ CELLS TRANSDUCED WITH RETROVIRAL VECTOR THAT ENCODES FOR THE HUMAN ADA CDNA SEQUENCE
  • Sponsor:Unidade Local De Saude De Coimbra E.P.E.

Biotinidase deficiency

Not yet recruiting

Study on the Effectiveness of Biotin and Biotin Sodium for Children with Metabolic Disorders

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Biotin
  • Sponsor:Fundacion Publica Galega Instituto De Investigacion Sanitaria De Santiago De Compostela

Study Comparing ABP 692 and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Ocrelizumab
  • Sponsor:Amgen Inc.

Study on the Effectiveness and Safety of Masitinib with Riluzole for Patients with Amyotrophic Lateral Sclerosis (ALS)

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Masitinib
  • Sponsor:Ab Science

Substances studied in this area

The therapies tested most often in Nervous system disorders trials.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.